News & Insights
Sort By
Events 1 result
Events
|October 25, 2023
Gunderson Dettmer will be sponsoring a series of Emerging Manager Leadership Dinners in connection with Venture Forward, a nonprofit founded by the NVCA to support the emerging manager ecosystem.
Client News 16 Results
Client News
|July 24, 2025
TCG Labs Soleil Announces $400M Funding Raise
Venture firm integrating capital with an in-house biotech R&D hub, TCG Labs Soleil, announces its $400 million funding raise
Client News
|September 30, 2024
DCVC Bio Announces $400M Fund Formation
DCVC Bio, a biotechnology venture fund investing in scientific breakthroughs by top innovators, announces the formation of its $400 million fund, DCVC Bio III
Client News
|February 1, 2024
TCG Labs-Soleil Announces Over $400M Inaugural Fund Formation
TCG Labs-Soleil announced its inaugural fund of over $400 million to establish and oversee a suite of portfolio companies, each focused on individual single-asset programs.
Firm News 3 Results
Firm News
|July 7, 2025
Recent Fund Formations Represented by Gunderson Dettmer*
Gunderson Dettmer provides a range of its recent fund formation deals that were closed.
Firm News
|April 17, 2024
Meet the Newest Fund Partners at Gunderson Dettmer
Meet Jason Ford and Chris Partin, our newest Fund Partners from the 2024 partner class.
Firm News
|December 14, 2023
Gunderson Dettmer Announces Seven Newly Elected Partners
Gunderson Dettmer has elected seven new partners, effective January 1, 2024. These newly promoted partners serve clients throughout the innovation economy from several of the firm’s core practices: Corporate & Securities, Fund Formation, Mergers & Acquisitions and Strategic Transactions & Licensing.